It includes Cepia team members Meoïn Hagège, PhD (principal investigator) and Florence Canouï-Poitrine, MD PhD; and IRD anthropologist Dolorès Pourette, PhD; ORS public health physician Emmanuelle Rachou, MD; CHU Réunion Cancer registry director Emmanuel Chirpaz MD; and CHU Réunion head of clinical research Catherine Marimoutou, MD.
Isocarma is funded for 4 years by the French Institute for Cancer research (INCa).